Key result
Primary care selective-prevention programs yield ~47% overall patient acceptance, with wide international variation.
Why the study?
Cardiometabolic diseases are the leading cause of death worldwide, prompting an evaluation of the implementation of primary care selective-prevention services across five European countries.
Cross-Sectional (n=1,000)
Yes
There is a high level of variability in the acceptance and implementation feasibility of selective CMD prevention services across different European primary care contexts.
Answers are grounded in this paper and cite their sources.
Substantial cross-country variation in acceptance of cardiometabolic prevention services warrants caution against uniform rollout; leaves open tailored implementation strategies.
(1) Background: Cardiometabolic diseases are the most common cause of death worldwide. As part of a collaborative European study, this paper aims to explore the implementation of primary care selective-prevention services in five European countries. We assessed the implementation process of the selective-prevention services, participants' cardiometabolic profile and risk and participants' evaluation of the services, in terms of feasibility and impact in promoting a healthy lifestyle. (2) Methods: Eligible participants were primary care patients, 40-65 years of age, without any diagnosis of cardiometabolic disease. Two hundred patients were invited to participate per country. The extent to which participants adopted and completed the implementation of selective-prevention services was recorded. Patient demographics, lifestyle-related cardiometabolic risk factors and opinions on the implementation's feasibility were also collected. (3) Results: Acceptance rates varied from 19.5% (n = 39/200) in Sweden to 100% (n = 200/200) in the Czech Republic. Risk assessment completion rates ranged from 65.4% (n = 70/107) in Greece to 100% (n = 39/39) in Sweden. On a ten-point scale, the median (25-75% quartile) of participant-reported implementation feasibility ranged from 7.4 (6.9-7.8) in Greece to 9.2 (8.2-9.9) in Sweden. Willingness to change lifestyle exceeded 80% in all countries. (4) Conclusions: A substantial variation in the implementation of selective-prevention receptiveness and patient risk profile was observed among countries. Our findings suggest that the design and implementation of behavior change cardiometabolic programmes in each country should be informed by the local context and provide some background evidence towards this direction, which can be even more relevant during the current pandemic period.
No takes yet. Share an insight, caveat, or question.
Lionis et al. (2020) conducted a cross-sectional in Without diagnosis of cardiometabolic disease (n=1,000). Selective-prevention services (CVD-risk assessment) was evaluated on Acceptance rate. The implementation of primary care selective-prevention services yielded an overall acceptance rate of 47.4%, with substantial variation among the five countries ranging from 19.5% to 100%.
Synapse has enriched 10 related papers. Consider them for comparative context: